Analyst Price Target is $163.25
▲ +14.61% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for CONMED in the last 3 months. The average price target is $163.25, with a high forecast of $175.00 and a low forecast of $158.00. The average price target represents a 14.61% upside from the last price of $142.44.
Current Consensus is
The current consensus among 4 investment analysts is to buy stock in CONMED. This Buy consensus rating has held steady for over two years.
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.